The chemotherapeutic agents substantially increased the proportion and number of CD45+ immune cells, especially the proportion and number of tumor-infiltrating CD8+ TILs, and enhanced the secretion of IFN-γ and TNF-α. Here, PTPRC is linked to neoplasm.